Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies Omar DabbousLylia ChachouaMondher Toumi Review Open access 01 December 2022 Pages: 393 - 424
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study Iain A. GillespieK. Arnold ChanDickens Theodore Original Research Open access 09 November 2022 Pages: 425 - 444
Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System Stephen D. SilbersteinShoshana ReshefAndrew Blumenfeld Original Research Open access 09 November 2022 Pages: 445 - 459
Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia: Results on Secondary Prevention from the German PROCYON Survey Umidakhon MakhmudovaMichaela WolfOliver Weingärtner Original Research Open access 10 November 2022 Pages: 460 - 473
Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn’s Disease: Results from a Global Survey of Patients and Gastroenterologists Miguel RegueiroTheresa HunterApril N. Naegeli Original Research Open access 12 November 2022 Pages: 474 - 488
Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective Wenwen XieYinyin SongPengfei Jin Original Research 12 November 2022 Pages: 489 - 503
Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database Artak KhachatryanIndraraj Umesh DoobareeMatthew Fay Original Research 18 November 2022 Pages: 504 - 520
Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis Yuwei LiuJiahui PanXingshun Qi Original Research 18 November 2022 Pages: 521 - 549
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea Joo-Young ByunJu-Eun LeeEui-Kyung Lee Original Research 20 November 2022 Pages: 550 - 567
Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia Mussa H. AlMalkiHossam AldesokeyAhmed Haroun Original Research Open access 22 November 2022 Pages: 568 - 584
Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305) Lauren C. PowellGilbert L’ItalienRichard B. Lipton Original Research Open access 22 November 2022 Pages: 585 - 600
Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study A Ana Borić-BilušićNada BožinaVladimir Trkulja Original Research 25 November 2022 Pages: 601 - 618
Phloroglucinol-Derived Medications are Effective in Reducing Pain and Spasms of Urinary and Biliary Tracts: Results of Phase 3 Multicentre, Open-Label, Randomized, Comparative Studies of Clinical Effectiveness and Safety Angela CorvinoElisa MagliGiovanna Maria Pierantoni Original Research Open access 29 November 2022 Pages: 619 - 640
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease Ana Filipa AlexandreAntonia MorgaKevin Marsh Original Research Open access 30 November 2022 Pages: 641 - 657
A Pharmacokinetic Drug–Drug Interactions Study between Entecavir and Hydronidone, a Potential Novel Antifibrotic Small Molecule, in Healthy Male Volunteers Rui ZhangPeixia LiShaojun Shi Original Research 07 December 2022 Pages: 658 - 670
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly Dermot O’ToolePamela L. KunzAlly Prebtani Original Research 11 December 2022 Pages: 671 - 690
Real-World Clinical Outcomes Based on Body Mass Index and Annualized Weight Change in Patients with Idiopathic Pulmonary Fibrosis Joyce S. LeeAdam Martin-SchwarzeCindy Burg Brief Report Open access 08 December 2022 Pages: 691 - 704
The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma Wenming ChenAijun LiuLin Li Study Protocol Open access 04 December 2022 Pages: 705 - 717
Correction to: A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis Haruki KoikeRyoji NishiMasahisa Katsuno Correction 12 November 2022 Pages: 718 - 718
Correction to: Identifying Patients for Self-Administration of Omalizumab Kevin R. MurphyTonya WindersBradley E. Chipps Correction Open access 18 November 2022 Pages: 719 - 719
Correction to: Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis Adrian SkellyNicholas TaylorLouise Downey Correction Open access 30 November 2022 Pages: 720 - 720
Correction to: A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing Sai Phanindra VenkatapurapuRyuichi IwakiriJovelle Fernandez Correction Open access 13 December 2022 Pages: 721 - 721
